ArticleProbiotics and antimicrobial proteins2026
Lacticaseibacillus Paracasei CCFM1350 Demonstrates Potentials in Hair Growth and Treating Alopecia in Mice.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Alopecia, a prevalent condition characterized by patterned or complete hair loss, significantly impacts quality of life. Effective treatments require modulation of underlying biological pathways rather than addressing superficial damage to skin or hair follicles. This study investigates Lacticaseibacillus paracasei CCFM1350 live bacteria as a potential intervention for promoting hair growth and treating alopecia. Through a series of animal experiments and biochemical assays, we demonstrate that CCFM1350 live bacteria significantly enhance hair growth via the Wnt/β-catenin signaling pathway. Specifically, the administration of CCFM1350 resulted in a 3.464-fold increase in hair growth compared to the control group. This effect was associated with a 243% increase in Wnt10b expression and a 35.56% increase in β-catenin expression. Additionally, significant alterations in the gut microbiota were observed in the CCFM1350-treated group, including changes in the abundance of Verrucomicrobia and Bacteroidetes at the phylum level and Akkermansia at the genus level. These findings suggest that L. paracasei CCFM1350 could serve as a viable probiotic treatment for alopecia, providing a natural alternative to conventional drugs like Finasteride.
Indexed as
Identifiers
41236601What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.